Nov 29, 2022 / 10:10PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us. I think this is the last presentation, but perhaps one of the key ones for us. A pleasure to have with us the team from Medtronic. We have the CEO, Geoff Martha, CFO, Karen Parkhill. And I think in the background, we have Ryan Weispfenning from Investor Relations. Geoff and Karen, thank you both for taking the time with us this afternoon. I think Geoff, you had some prepared remarks, a few opening remarks, and then now we can dive into Q&A.
Geoffrey Straub Martha - Medtronic plc - Chairman of the Board & CEO
Yes, sure. Thanks, Vijay, and thanks for having us, and thanks for everyone joining this session today. As you know, just last week, we reported our fiscal Q2 results where we had a top line miss, which we were able to -- a top line miss consensus, which we were able to offset coming in on the bottom line coming in on the high end of
Medtronic PLC at Evercore ISI HealthCONx Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot